Literature DB >> 12162407

3-Hydroxy-3-methylglutaryl coenzyme A reductase activity and low-density lipoprotein receptor expression in diffuse-type and intestinal-type human gastric cancer.

Maria Gabriella Caruso1, Maria Notarnicola, Aldo Cavallini, Alfredo Di Leo.   

Abstract

BACKGROUND: Cancer cells require more cholesterol than normal cells. This requirement may be satisfied by higher hydroxymethylglutaryl coenzyme A reductase activity or low-density lipoprotein receptor expression or both. We investigated hydroxymethylglutaryl coenzyme A reductase activity and low-density lipoprotein receptor expression in samples of gastric carcinoma and normal mucosa obtained from 30 patients. The samples of gastric carcinoma were divided into two categories according to Lauren's classification: diffuse-type and intestinal-type.
METHODS: Hydroxymethylglutaryl coenzyme A reductase activity was measured by radiometric assay and low-density lipoprotein receptor expression was measured by enzyme-linked immunosorbent assay.
RESULTS: Hydroxy-methyl-glutaryl-coenzyme A reductase activity was significantly higher in neoplastic tissue than in normal mucosa, both in diffuse-type and intestinal-type gastric cancer. Low-density lipoprotein receptor levels were significantly lower in neoplastic tissue than in normal mucosa of diffuse-type gastric cancer, whereas no significant difference was present between neoplastic tissue and normal mucosa in intestinal-type gastric cancer. Hydroxymethylglutaryl coenzyme A reductase activity did not differ between intestinal-type and diffuse-type neoplastic samples, while low-density lipoprotein receptor levels were significantly higher in intestinal-type than in diffuse-type gastric cancer tissue.
CONCLUSIONS: These findings show different behavior of cholesterol metabolism in the two types of gastric carcinoma and, therefore, suggest that different therapeutic strategies should be adopted.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12162407     DOI: 10.1007/s005350200078

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  14 in total

1.  Role of cholesterol in the development and progression of breast cancer.

Authors:  Gemma Llaverias; Christiane Danilo; Isabelle Mercier; Kristin Daumer; Franco Capozza; Terence M Williams; Federica Sotgia; Michael P Lisanti; Philippe G Frank
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

2.  Mevalonate Pathway Antagonist Suppresses Formation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models.

Authors:  Yusuke Kobayashi; Hiroyasu Kashima; Ren-Chin Wu; Jin-Gyoung Jung; Jen-Chun Kuan; Jinghua Gu; Jianhua Xuan; Lori Sokoll; Kala Visvanathan; Ie-Ming Shih; Tian-Li Wang
Journal:  Clin Cancer Res       Date:  2015-06-24       Impact factor: 12.531

Review 3.  Cancer prevention and therapy through the modulation of the tumor microenvironment.

Authors:  Stephanie C Casey; Amedeo Amedei; Katia Aquilano; Asfar S Azmi; Fabian Benencia; Dipita Bhakta; Alan E Bilsland; Chandra S Boosani; Sophie Chen; Maria Rosa Ciriolo; Sarah Crawford; Hiromasa Fujii; Alexandros G Georgakilas; Gunjan Guha; Dorota Halicka; William G Helferich; Petr Heneberg; Kanya Honoki; W Nicol Keith; Sid P Kerkar; Sulma I Mohammed; Elena Niccolai; Somaira Nowsheen; H P Vasantha Rupasinghe; Abbas Samadi; Neetu Singh; Wamidh H Talib; Vasundara Venkateswaran; Richard L Whelan; Xujuan Yang; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2015-04-10       Impact factor: 15.707

4.  Elevated paraneoplastic hypercholesterolemia in a case of hepatoid adenocarcinoma of the stomach with liver metastasis.

Authors:  Tetsuro Sohda; Hiroyuki Kusuhara; Yoshiki Egashira; Keisuke Egashira; Koichi Eguchi; Kunihiko Aoyagi; Shotaro Sakisaka
Journal:  Clin J Gastroenterol       Date:  2013-09-14

5.  Low scavenger receptor class B type I expression is associated with gastric adenocarcinoma tumor aggressiveness.

Authors:  Xingwen Wang; Changshun Wu; Baoying Yuan; Dan Wang; Huiling Liu; Hong Feng; Shui Sun
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

6.  Anticancer activity of the cholesterol exporter ABCA1 gene.

Authors:  Bradley Smith; Hartmut Land
Journal:  Cell Rep       Date:  2012-09-13       Impact factor: 9.423

7.  Anticancer effects of Chinese red yeast rice versus monacolin K alone on colon cancer cells.

Authors:  Mee Young Hong; Navindra P Seeram; Yanjun Zhang; David Heber
Journal:  J Nutr Biochem       Date:  2007-09-14       Impact factor: 6.048

8.  Dietary-suppression of hepatic lipogenic enzyme expression in intact male transgenic mice.

Authors:  Maria Notarnicola; Maria Gabriella Caruso; Angela Tafaro; Valeria Tutino; Giusy Bianco; Mario Minoia; Antonio Francavilla
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

9.  Cholesterol import and steroidogenesis are biosignatures for gastric cancer patient survival.

Authors:  Wei-Chun Chang; Shang-Fen Huang; Yang-Ming Lee; Hsueh-Chou Lai; Bi-Hua Cheng; Wei-Chung Cheng; Jason Yen-Ping Ho; Long-Bin Jeng; Wen-Lung Ma
Journal:  Oncotarget       Date:  2017-01-03

Review 10.  The prince and the pauper. A tale of anticancer targeted agents.

Authors:  Alfonso Dueñas-González; Patricia García-López; Luis Alonso Herrera; Jose Luis Medina-Franco; Aurora González-Fierro; Myrna Candelaria
Journal:  Mol Cancer       Date:  2008-10-23       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.